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Abstract
Background
Given the high prevalence of chronic kidney disease (CKD), primary care physicians
(PCPs) frequently manage early stage CKD. Nonetheless, there are challenges in providing
optimal CKD care in the primary care setting. This study sought to understand PCPs’ per-
ceptions of barriers and facilitators to the optimal management of CKD.
Study design
Mixed methods study
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Settings and participants
Community-based PCPs in four US cities: Baltimore, MD; St. Louis, MO; Raleigh, NC and
San Francisco, CA.
Methodology
We used a self-administered questionnaire and conducted 4 focus groups of PCPs (n = 8
PCPs/focus group) in each city to identify key barriers and facilitators to management of
patients with CKD in primary care.
Analytic approach
We conducted descriptive analyses of the survey data. Major themes were identified from
audio-recorded interviews that were transcribed and coded by the research team.
Results
Of 32 participating PCPs, 31 (97%) had been in practice for >10 years, and 29 (91%) prac-
ticed in a non-academic setting. PCPs identified multiple barriers to managing CKD in pri-
mary care including at the level of the patient (e.g., low awareness of CKD, poor adherence
to treatment recommendations), the provider (e.g., staying current with CKD guidelines),
and the health care system (e.g., inflexible electronic medical record, limited time and
resources). PCPs desired electronic prompts and lab decision support, concise guidelines,
and healthcare financing reform to improve CKD care.
Conclusions
PCPs face substantial but modifiable barriers in providing care to patients with CKD. Inter-
ventions that address these barriers and promote facilitative tools may improve PCPs’ effec-
tiveness and capacity to care for patients with CKD.
Introduction
Patients with chronic kidney disease (CKD) are medically complex, with a high likelihood of
significant comorbidity and an increased risk of progression to end stage renal disease and
death.[1, 2] Recognized as a public health priority, CKD ranks 18th in causes of death world-
wide in 2010 and 9th in the United States in 2015.[3, 4] The past 20 years has witnessed an 82%
increase in deaths worldwide due to kidney disease, an increase similar to that of diabetes mel-
litus and greater than cancer.[3] Moreover, the prevalence of CKD in the United States is esti-
mated at 15% of the non-institutionalized adult population, corresponding to over 2000
patients per U.S. nephrology provider.[5, 6] In light of the sizeable at-risk population, primary
care physicians (PCPs) may have to provide the bulk of care for patients with early (Stage 1–3)
CKD. PCPs, however, have been shown to suboptimally recognize and manage patients with
CKD.[7–11] This mixed methods study sought to better understand PCPs’ perceptions of
patient-, provider-, and systems-level barriers to CKD management in the primary care set-
ting. In addition, we sought PCPs’ views on potential facilitators to high quality CKD care
delivery.
Barriers to PCP management of CKD
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Materials and methods
Using a mixed-methods approach, we conducted a self-administered survey and four qualita-
tive focus groups of 32 PCPs in four U.S. cities (Baltimore, MD, St. Louis, MO, Raleigh, NC
and San Francisco, CA) (n = 8 PCPs/focus group in each city) to identify 1) PCPs’ perceived
barriers to the care of patients with CKD, and 2) PCPs’ views of potential tools and resources
which could improve their care of patients with CKD. Both qualitative and quantitative data
were used to obtain a deeper, broader understanding of the challenges PCPs experience in the
provision of CKD care and to increase the validity of the findings.
PCPs from each city were purposively recruited by Baltimore Research (Towson, MD) to
participate. Baltimore Research recruits providers from an internal list of physicians who have
previously opted to participate in research studies. To be eligible for participation, respondents
needed to have at least one half day clinic per week, see >40 patients per month, spend the
majority of their clinical time delivering outpatient primary care, and provide care for patients
with CKD. Since PCPs from different specialties (i.e., family practice and internal medicine),
practice settings (i.e., community-based and university/medical school-based practice), gen-
ders (i.e., male and female), and racial/ethnic populations (i.e., included PCPs identifying as
Black/African American, Hispanic/Latino, Native American, Native Hawaiian or Other Pacific
Islander) may perceive different barriers to delivery of optimal CKD care, we pre-determined
that each focus group would have at least 1–2 PCPs from each of the above specified groups.
We selected a sample size (32 participants, 4 focus groups) expected to provide adequate satu-
ration of major themes. All participants were informed of the overall goal of the study and
written consent was obtained. The study protocol was approved by The Johns Hopkins Medi-
cine Institutional Review Board. We did not systematically gather information from providers
who received an invitation from Baltimore Research but did not participate in the study.
Each 90-minute focus group session was conducted between April and June 2015 at Balti-
more Research or affiliated location. Data on physicians’ demographic and practice character-
istics, comfort with managing and educating patients with CKD, and access to clinical
management tools were obtained via a brief self-administered questionnaire (S1 Appendix)
developed by a team with clinical expertise in CKD. Questions featured a 5 point Likert scale
ranging from strongly agree to strongly disagree, and responses were categorized as strongly
agree and agree versus neutral, disagree or strongly disagree. The focus group discussion
began immediately following completion of the questionnaire. One investigator (RCG), a
female general internist and health service researcher with expertise in qualitative methods[9,
12, 13] and no prior relationship with study participants, conducted all sessions using a stan-
dardized question guide developed by the National Kidney Foundation Education Committee
(RCG, KC, CJD, MME, KA, VA, JAV, MJC, and BGJ). The question guide was further refined
by physicians with expertise in primary care, nephrology, and qualitative research methods.
The question guide consisted of open-ended questions with the goal of identifying PCPs’ per-
ceived barriers and facilitators to the care of patients with CKD (Box 1). The question guide
was refined in an iterative fashion to address emerging themes from prior focus group ses-
sions. The focus group moderator (RCG) took field notes during and after the focus session.
The focus groups were audiotaped and transcribed verbatim for thematic content analysis.
[14, 15]
We used descriptive statistics to describe questionnaire responses. We used content analysis
to analyze the focus group discussions related to the diagnosis of CKD, evaluation of CKD,
management of CKD, risk factors for CKD progression and CKD-related complications, and
educating patients about CKD. Two investigators (RCG and YL) independently reviewed the
first 2 focus groups transcripts to develop an initial coding scheme using an inductive
Barriers to PCP management of CKD
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approach representing the relevant concepts (i.e., codes emerged from the data and were not
predefined). [14, 15] Descriptive codes were assigned to segments of text of varying size that
describe the challenges or facilitators PCPs experience in caring for their patients with CKD.
The investigators then reviewed the initial coding schemes together and agreed upon a final
Box 1. Interview guide
Primary care physician interview questions and probes
Demographics
• Briefly describe your practice setting.
• How long have you been in practice?
Patient characteristics
• Briefly describe your typical patient with CKD.
Approach to CKD screening
• What are the challenges you face in screening patients for CKD?
• Describe resources, tools, or features of your practice that make it easier to screen for
CKD.
• What would be helpful in screening patients for CKD?
Experience with managing CKD
• What are the biggest challenges you face in managing patients with CKD?
• Of the following, what are the 2 most challenging and 2 least challenging aspects of
care to manage in patients with CKD? Why?
� Diagnosis of CKD
� Evaluation of CKD cause
� Managing risk factors for CKD progression
� Assessment and management of CKD complications
� Medication safety
� Educating patients with CKD
• Describe resources, tools, or practice features that help you address these aspects of
care.
• What would be helpful in addressing these aspects of care in patients with CKD?
Tools to facilitate care
• What would you incorporate into your practice to help you care for patients with
CKD?
Barriers to PCP management of CKD
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coding scheme that was applied to all transcripts. Any new codes identified from the review of
the additional focus group transcripts were reviewed and added to the final coding scheme.
The codes were subsequently categorized into a final list of major themes and subthemes
regarding PCPs’ perceptions of barriers and facilitators to the care of patients with CKD. The
themes were then organized to describe the PCPs’ perceived barriers at the patient, provider,
and system-level. Evidence of thematic saturation was noted when no new themes were identi-
fied in the fourth focus group discussion. We compared the findings from the quantitative and
qualitative data. We informally reviewed our study results with PCPs at our institution and
study team members with expertise in the clinical care of CKD. ATLAS.ti version 5.0.
(ATLAS.ti GmbH, Berlin, Germany) was used for data management.
Results
More than half (n = 22, 69%) of the PCP respondents practiced in a single-specialty private
practice, with only 9% (n = 3) in a teaching hospital (Table 1). The PCPs had a mean age of 53
±8 years and were predominately male (n = 19, 59%) and white (n = 21, 66%). Most possessed
an MD degree (versus DO) (n = 30, 94%) and had been in practice for more than 15 years
(n = 23; 72%). Respondents spent most of their time in clinical practice (median percent clini-
cal time 98 [IQR 88–100]) and 38% (n = 12) saw more than 100 patients per week. Twenty-
two (69%) respondents saw more than 10 patients with CKD per week.
Forty-five percent (n = 14) of PCPs reported that they did not follow CKD guidelines.
Table 2 summarizes PCP-reported comfort with managing CKD and the availability of tools to
facilitate that care. Although most (n = 27, 84%) strongly agreed or agreed that they felt comfort-
able managing patients with CKD, many were not comfortable managing specific complications
of CKD such as anemia (n = 14, 44%), bone disorders (n = 16, 50%), and metabolic acidosis
(n = 22, 69%). PCPs frequently cited a lack of available tools to facilitate management of specific
complications of CKD, such as anemia (n = 21, 66%), hyperkalemia (n = 16, 50%), metabolic
acidosis (n = 22, 69%), and bone disorders (n = 23, 72%). Similarly, a lack of tools and resources
for educating patients was noted for diagnosing CKD, hypertension management, medication
risks, anemia, hyperkalemia, bone disorders, and metabolic acidosis (44–78%).
PCP-identified themes
The data were organized into major themes and subthemes by patient-, provider-, and systems-
level barriers to CKD management, as well as potential facilitators of CKD management (Table 3).
Patient-level barriers to CKD management
PCPs identified patient-level barriers to optimal management of CKD to be patients’ poor
awareness and understanding of CKD, suboptimal adherence to treatment recommendations,
and high burden of healthcare costs to patients. PCPs expressed that patients often do not rec-
ognize or understand the diagnosis of CKD, and are often surprised at the diagnosis given the
frequent lack of attributable symptoms until late in the course of the disease:
“They’re not expecting [it] and many of them don’t have relating symptoms.”
PCPs felt patients’ lack of understanding of their CKD diagnosis and its implications on
their health may adversely affect self-management of their CKD risks. A provider remarked,
“Almost nobody is bothered by their chronic kidney disease until it’s way, way, way late stage,
so they’re not particularly motivated [to manage their risk factors for CKD progression].”
Barriers to PCP management of CKD
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Table 1. Characteristics of primary care physicians (N = 32).
Participant characteristics N (%)
Age, mean years (SD) 53 (8)
Gender
Male 19 (59)
Female 13 (41)
Race/ethnicity
White 21 (66)
Black or African American 2 (6)
Hispanic or Latino 2 (6)
Asian 5 (16)
Other 2 (6)
Medical specialty
Internal medicine 19 (59)
Family practice 13 (41)
Training
Doctor of Medicine (MD) 30 (94)
Doctor of Osteopathic Medicine (DO) 2 (6)
Practice setting
Solo private practice 10 (31)
Single specialty group private practice 12 (38)
Multispecialty group practice 5 (16)
University hospital or medical school 2 (6)
Community, teaching hospital 1 (3)
Community, non-teaching hospital 1 (3)
Government health care facility 1 (3)
Percent clinical time
� 80 30 (94)
< 80 2 (6)
Percent clinical time, median (IQR) 98 (88–100)
Percent research time, median (IQR) 0 (0–0)
Percent administrative time, median (IQR) 0 (0–10)
Number of patients per week
� 100 20 (62)
> 100 12 (38)
Number of CKD patients per week
10 or less 10
11–20 10
21–30 5
31–40 3
> 40 4
Number of years in practice
0–5
6–10 1 (3)
11–15 8 (25)
> 15 years 23 (72)
EHR use
yes, part EMR and part paper 8 (25)
yes, all EMR/yes, part EMR and part paper 1 (3)
(Continued)
Barriers to PCP management of CKD
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Physicians reported that since patients “don’t feel” their CKD, a discussion of CKD often
leads immediately to patients’ fears of dialysis or transplantation, rather than a dialogue on
chronic management. In this context, patient adherence to provider visits, diagnostic tests,
Table 1. (Continued)
Participant characteristics N (%)
yes, all EMR 23 (72)
Report following CKD guidelines
�
No 14 (45)
Yes 17 (54)
�
n = 31
https://doi.org/10.1371/journal.pone.0221325.t001
Table 2. PCP-reported comfort with managing CKD and access to clinical tools (n = 32).
N (%)
Themes Strongly Agree Agree Neutral Disagree Strongly Disagree
I feel comfortable:
making the diagnosis of CKD in my patients 15 (47) 15 (47) 2 (6) 0 (0) 0 (0)
educating my patients about CKD 9 (29) 18 (58) 4 (13) 0 (0) 0 (0)
managing my patients with CKD
�
8 (26) 19 (61) 4 (13) 0 (0) 0 (0)
managing medication dosing in my patients with CKD 5 (16) 21 (66) 6 (19) 0 (0) 0 (0)
avoiding nephrotoxic medications in my patients with CKD
�
13 (42) 17 (55) 1 (3) 0 (0) 0 (0)
managing hypertension in my patients with CKD 11 (34) 19 (59) 2 (6) 0 (0) 0 (0)
managing anemia of CKD in my patients 4 (13) 14 (44) 10 (31) 4 (13) 0 (0)
managing bone disorders of CKD in my patients 1 (3) 15 (47) 11 (34) 5 (16) 0 (0)
managing electrolyte disorders in my patients with CKD 3 (9) 18 (56) 8 (25) 2 (6) 1 (3)
managing metabolic acidosis in my patients with CKD 1 (3) 9 (28) 16 (50) 4 (13) 2 (6)
I have available tools which help me to:
diagnose CKD 8 (25) 16 (50) 5 (16) 3 (9) 0 (0)
manage CKD
�
6 (19) 16 (52) 6 (19) 3 (10) 0 (0)
manage medication dosing
�
6 (19) 19 (61) 3 (10) 3 (10) 0 (0)
avoid prescribing nephrotoxic medications 7 (22) 18 (56) 5 (16) 2 (6) 0 (0)
manage hypertension in my patients with CKD 4 (13) 18 (56) 7 (22) 3 (9) 0 (0)
manage anemia of CKD 2 (6) 9 (28) 14 (44) 6 (19) 1 (3)
manage bone disorders of CKD 2 (6) 7 (22) 17 (53) 5 (16) 1 (3)
manage hyperkalemia in CKD
��
2 (7) 12 (40) 10 (33) 5 (17) 1 (3)
manage metabolic acidosis in CKD 2 (6) 8 (25) 12 (38) 9 (28) 1 (3)
I have educational tools and resources available to help my patients understand:
their CKD diagnosis 3 (9) 15 (47) 7 (22) 6 (19) 1 (3)
the potential medication-related risks associated with CKD 2 (6) 13 (41) 10 (31) 6 (19) 1 (3)
anemia of CKD
�
2 (6) 6 (19) 13 (42) 8 (26) 2 (6)
hypertension in CKD 3 (9) 13 (41) 9 (28) 5 (16) 2 (6)
bone disorders in patients with CKD 2 (6) 6 (19) 14 (44) 8 (25) 2 (6)
hyperkalemia in CKD 3 (9) 6 (19) 13 (41) 8 (25) 2 (6)
metabolic acidosis in CKD 2 (6) 5 (16) 12 (38) 10 (31) 3 (9)
�
n = 31;
��
n = 30; Abbreviation: Chronic kidney disease (CKD)
https://doi.org/10.1371/journal.pone.0221325.t002
Barriers to PCP management of CKD
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Table 3. Primary care physicians’ perceived barriers and facilitators to CKD management.
BARRIERS
Major themes Subthemes
Patient-level
Patients’ limited understanding about CKD and
its’ implications
Patients with CKD are asymptomatic
Patients often do not appreciate importance of CKD
Patients’ limited CKD knowledge and lack of symptoms
contribute to decreased adherence with recommended
treatment
Patients unable to afford recommended CKD
care
Multiple medications, tests, and referrals for patients with CKD
contribute to substantial health care costs
Provider-level
PCPs’ limited recognition or knowledge about
CKD
PCPs may understand CKD less well than other areas of
medicine
CKD may not recognize CKD or add it to the problem list
PCPs’ lack of awareness of CKD guidelines or
useful algorithms for CKD care
Existing guidelines are not aggressively disseminated
Existing guidelines are unclear
Difficult to stay up-to-date with changing guidelines
CKD risk factors (blood pressure, diabetes,
obesity) are difficult to manage
Blood pressure management is difficult
Lack of patient access to self-monitoring tools (blood pressure
monitoring kit)
Conflicting treatment goals from different specialists
Difficulty engaging patients in CKD self-management
PCPs’ belief that they are unable to improve CKD Belief that CKD is not reversible
Systems-level
Limited visit time to care for complex patients Healthcare system does not allow adequate time for
management of complex patients
Poor reimbursement for delivering optimal CKD
care
Limited reimbursement does not facilitate complex care
More frequent visits may increase reimbursement but are
unduly burdensome to patients
Lack of comprehensive clinical information
systems (EMR)
EMRs lack sufficient flexibility for chronic disease management
(e.g., patient registries)
Insufficient clinical support tools and resources to
support patient-self-management
Inadequate patient educational material about CKD
Lack of physician extenders, dietitians, educators, etc.
FACILITATORS
Major themes Subthemes
Decision support integrated into daily practice Electronic care prompts
Best practice / guideline support within laboratory reports
Automated eGFR reporting Automated eGFR reporting to improve PCPs’ CKD recognition
Team-based care Better access to and utilization of dietitians, case managers,
pharmacists, and health educators
Concise clear guidelines and CKD protocols Useful guides to managing CKD as well as specific CKD
complications (e.g., electrolyte abnormalities, metabolic
acidosis)
Improved insurance coverage and reimbursement
for CKD care activities
Improve compensation for CKD care
Better align insurance coverage with clinical guidelines
Better CKD-related educational tools Increase opportunities for PCP education in CKD
Improve patient access to education and self-management
resources
Raise awareness of CKD within the general population
Abbreviations: Chronic kidney disease (CKD); primary care physician (PCP); electronic medical record (EMR),
estimated glomerular filtration rate (eGFR)
https://doi.org/10.1371/journal.pone.0221325.t003
Barriers to PCP management of CKD
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medications, and lifestyle approaches to self-care does not meet PCP expectations. A PCP
remarked:
“You can order the tests, but . . .if they don’t understand why it’s important they’re not going
to come in.”
Out-of-pocket healthcare costs were also viewed as a barrier to patients’ adherence to pro-
vider recommendations:
“To the compliance issue, if the patient is on multiple medications and seeing multiple special-
ists, so they have to balance cost. So a lot of time cost is an issue.”
This concern was further reinforced in patients having to take time off from work to attend
visits:
“Somebody’s taken a day off of work to bring mom in who has otherwise no transport, so that
person’s already out of work. Do you think they want to take another vacation day to come
back in two weeks? No.”
Provider-level barriers to CKD management
PCPs identified numerous physician-level barriers in the management of CKD. They noted
their lack of CKD knowledge, particularly regarding management of advanced CKD; poor
awareness of CKD guidelines or difficulty implementing guidelines that are perceived to change
frequently; and complexity of managing multiple comorbid illnesses with conflicting goals of
care. Furthermore, they described a fatalistic belief that CKD is incurable and only likely to
worsen, as well as difficulty engaging patients in modification of their CKD risk factors.
Some PCPs identified a lack of knowledge of CKD:
“I feel like there's a lot of areas within medicine that I know a lot about. . .but renal. . ..It's not
my super comfort zone”
PCPs also described lack of recognition of CKD due to use of creatinine rather than esti-
mated glomerular filtration rate (eGFR) or lack of documentation of CKD on the problem list
as barrier to CKD management:
“The lab did not calculate the GFR. . .I think that we probably missed a lot. . . [because] a cre-
atinine 1.3. . .looks all right. . ..”
“If somebody's creatinine is 2.5 and you know its chronic kidney disease but that problem is
not on the problem list, there's no flag. . ..that. . .triggers. . .the interaction. . ..”
Some PCPs had limited familiarity with CKD guidelines, while others perceived an absence
of clear, easily applied algorithms for the management of CKD:
“I know there’s like the National Kidney Foundation, but I feel like the ADA guidelines are
much more useful. . . I mean I certainly don’t know them [CKD guidelines] very well and I
can’t visualize an algorithm from them.”
“A good algorithm. I mean there are a lot of good algorithms for diabetes; there’s lots of good
algorithms for hypertension. I haven’t seen a good algorithm for stage III kidney disease.”
Barriers to PCP management of CKD
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This perception of limited guidance from professional societies may be further exacerbated
by recommendations that change over time with inadequate dissemination to practitioners:
“And I think because a lot of those guidelines and rules change over time, there’s just a lot of
confusion. So I think it is kind of this squishy black hole to a lot of primary care doctors as far
as the nitty gritty details.”
PCPs believed the management of patients with CKD was also complicated by the complex-
ity of their medical issues and the difficulty in managing these comorbid illnesses such as
hypertension, which sometimes is “very hard to control” later in kidney disease. Measuring
blood pressure four times a year at an in-office visit was also noted as likely insufficient for
best management. Managing comorbid illnesses of relevance to CKD progression was also per-
ceived to be complicated by conflicting recommendations on goals of care based on other asso-
ciated co-morbidities (e.g., blood pressure targets in patients with cardiovascular disease and
CKD). A cardiologist, for instance, may be pleased when the blood pressure is lowered to 110/
80, while the nephrologist is advocating for a higher target.
PCPs also described the struggles and frustrations they experience in engaging patients in
self-management of risk factors for CKD progression. A provider stated:
“What’s going to make them listen now if I’ve been doing that for the last 10 years before they
got to the [CKD]? It’s a little bit frustrating.”
Another provided commented:
“It's a challenge to keep on top and keep your patients motivated to stay on the plan.”
They also reflected that CKD is a difficult concept to explain and that during the visit they
may place less emphasis on CKD compared to other conditions which may hamper patients’
recognition of the implications of CKD:
“We're worrying about and thinking and monitoring their kidney disease but how much time
are we really spending educating them and talking to them about it? Probably not that much.
Which may then mean to them I guess I don't need to worry about it that much.”
All of these provider-level barriers may be reinforced by a belief among some PCPs that
CKD is incurable and unlikely to improve. A PCP commented:
“If the blood pressure is high, I put them on blood pressure medicine, and I fixed it. If you
have chronic kidney disease, you still have chronic kidney disease. You can’t fix it. All you can
do is [ensure]. . . it doesn’t worsen. We’re not helping. . .it’s not very exciting.”
When combined with PCPs’ perceived difficulty in engaging patients in their CKD care,
PCPs may be further disincentivized to address the problem. Yet, some respondents also
espoused a nuanced view of CKD management, suggesting that reframing expectations in
CKD care may be required:
“Maybe the excitement will come 25 years from now as far as this patient never getting to dial-
ysis. It’s sort of a delayed gratification. . . This one might be just very, very delayed.”
Barriers to PCP management of CKD
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Systems-level barriers to CKD management
In addition, PCPs believed that inefficiencies in the health care system hindered CKD manage-
ment. These challenges included insufficient time for managing a complicated disease process
such as CKD in patients who often have multiple medical problems, as well as limited reim-
bursement, rigid electronic medical record (EMR) templates, and inadequate clinical support
and resources. PCPs focused heavily on time constraints within a healthcare delivery system that
is not optimized for the management of patients with multi-morbidity, nor the management of
a multi-faceted disease process such as CKD. As care of the CKD patient necessitates patient
education and management of hypertension, diabetes, anemia, and other comorbid illnesses or
acute concerns, there is often insufficient time in a clinic visit to address all relevant medical and
behavioral topics. Thus, it is easy to deprioritize CKD or defer management until another visit:
“I think during the 15 or 20 minutes you have with the patient appointment, your agenda’s
long. You need to deal with their blood pressure and their diabetes and they may come in
because their back’s hurting or something else.”
“The patient is not symptomatic, the patient is not going to complain about it [CKD], so you
worry about the sore throat for the day or the cholesterol and so on.”
PCPs identified insufficient reimbursement as a barrier to providing better care. While they
noted increased reimbursement for more frequent visits, a lack of appointment availability was
identified as a limiting factor. In addition, PCPs indicated that not all laboratories automati-
cally report eGFR to facilitate recognition of CKD; EMR systems were not optimized for
chronic disease management; adequate educational resources were not available (e.g., patient
educational material for non-English speaking patients), and many practices lacked physician
extenders to facilitate longitudinal care and patient education.
Facilitators of CKD management
Respondents also proposed numerous facilitators to address these barriers to CKD manage-
ment. PCPs desired decision support (e.g., electronic prompts with EMR or laboratory-based),
automatic eGFR reporting by all laboratories, more robust team-based care, concise and clear
CKD guidelines, increased compensation and better insurance coverage for CKD care activi-
ties, and better CKD-related educational tools to facilitate CKD management. PCPs felt it
would be helpful to have prompts integrated in their daily practice to remind them of CKD
related care activities. For PCPs who had decision support within their EMR or through writ-
ten guidance that accompanied laboratory reports, they found it to be extremely helpful in
facilitating CKD care in accordance with guidelines. A PCP described,
“Our EMR has lots of pop-ups that tells exactly what to order and that’s helpful.”
PCPs also felt that automated eGFR reporting enhanced their recognition of CKD, and felt
it important that all laboratories universally report eGFR when a creatinine is ordered.
PCPs desired greater use of robust multi-disciplinary care teams, such as dietitians, case
managers, pharmacists, and health educators to facilitate patient education and self-manage-
ment of risk factors for CKD progression. Those PCPs who had access to these resources
found them extremely helpful:
“It does help as we shift more towards population management and value over volume–medi-
cal home as a model becomes key in chronic disease management.”
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Respondents believed ready access to clear and concise CKD guidelines was needed, includ-
ing for more challenging nephrology topics such as electrolytes and metabolic acidosis:
“If it were a really practical guide–which I have never seen personally–to managing those elec-
trolyte complications, I think that would be incredibly helpful.”
In addition, improved reimbursement for CKD care activities and alignment of insurance
coverage with those clinical guidelines to remove potential financial barriers for patients was
deemed important for effective CKD care delivery:
“I think if we were compensated better for the management of these chronic complex problems
we could actually spend more time with the patient and it wouldn't be as much of a
challenge. . .”
“I find lately, and probably the last 10–15 years, insurance guidelines actually trump the clini-
cal guidelines. And it’s unfortunate, but you cannot fight them, and you cannot explain to the
patients–this is what the nephrologist’s association says, but this is what your insurance says.
Where do you go from here?”
PCPs also desired additional educational resources to enhance their understanding of CKD
management (e.g., web-based tools and/or CME activities) as well as greater access and use of
effective education tools to facilitate patient CKD education. Ultimately, raising awareness of
CKD within the general population was believed to be critical. “More media coverage” and
“even public service announcements” might increase patient engagement in their CKD manage-
ment, and this might be further facilitated by dedicating visits specifically to CKD discussion.
In comparing the PCPs responses on the questionnaire with the themes identified in the
focus group discussions, the findings were similar. In both questionnaire and the focus groups,
physicians report lack of awareness and familiarity with CKD guidelines, limited comfort with
managing CKD (particularly CKD related complications), and lack of available resources to
facilitate optimal management of CKD or to improve patients’ self-management of their risk
factors for CKD progression. There were no obvious contradictions between the questionnaire
and focus group findings; however, the focus group provided more comprehensive under-
standing of the challenges providers were facing. For example, while the majority of providers
reported feeling comfortable with the diagnosis of CKD (94%) on the questionnaire, in the
focus groups, PCPs reported challenges with follow-up steps required to deliver optimal care
such as quantifying the severity of CKD or documenting it on the problem list so it can be
addressed routinely during subsequent follow-up visits. A provider commented:
“I know what the diagnosis is. The challenge is what stage is this or documenting the
diagnosis.”
Discussion
In this study, PCPs identified numerous challenges to providing optimal CKD care, including
patient- (e.g. patients’ limited understanding of CKD and inadequate adherence to recom-
mended treatment), physician- (e.g., PCPs’ limited familiarity with CKD guidelines, difficulty
with managing risk factors for CKD progression, and belief that they are unable to improve
CKD), and systems-level (e.g., limited visit time to care for complex patients, lack of compre-
hensive clinical information systems to track and plan care; and insufficient resources to sup-
port patient self-management of their CKD risks) barriers. They also identified facilitators that
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may provide solutions to some of these problems (e.g., concise clear guidelines and protocols,
decision support integrated into the EMR, and team-based care).
The findings from this study are consistent with other studies that have used various meth-
ods (e.g., questionnaires, medical record review, interviews or focus groups) to characterize
PCPs practice patterns and identify barriers to the management of CKD by PCPs.[9, 11, 13,
16–23] However, there are few studies that explore in-depth the reasons for ineffective CKD
care by US PCPs, whose experience in delivering CKD care may differ from other countries
with universal health care coverage.[9, 13, 16] This study builds on the existing evidence to
provide detailed views of the challenges US PCPs’ experience in caring for patients with CKD.
The findings from this study provide valuable insights that can be used to improve delivery of
CKD care in primary care settings in the US, and that may also be generalizable to PCPs prac-
ticing in other countries or caring for other conditions.
Patient-level barriers identified by the PCPs in our study included limited awareness and
understanding of CKD, inadequate adherence to treatment recommendations, and healthcare
costs. These findings are consistent with prior studies describing patients’ poor understanding
of CKD and its health implications.[24–28] A central tenet of contemporary medicine is that
informed patients have better health outcomes.[29] In CKD, however, studies have demon-
strated that knowledge of CKD among patients is quite low relative to other common chronic
diseases such as diabetes or hypertension.[24–28] CKD is conceptually difficult for patients to
understand, and effective management often requires significant financial cost and substantial
changes to diet and lifestyle to mitigate risks for CKD progression.[30, 31] PCPs can play a key
role in improving patients’ CKD awareness and self-management behaviors. Although the
majority of PCPs in our study reported feeling comfortable educating patients about CKD, on
further questioning they expressed challenges in improving patients’ understanding of their
CKD diagnosis and engaging them in risk factor modification. These findings emphasize the
need for greater dissemination of tools and resources to facilitate patient education about
CKD and to enhance patients’ understanding of CKD risks.[32] Linking CKD education to
other co-existent medical conditions, such as diabetes and hypertension, may enhance
patients’ CKD awareness and also facilitate increased delivery of CKD education during time
constrained visits.[27] Greater access to effective self-management support within primary
care (e.g., case management, community health workers services, referral to evidence-based
self-management education programs, caregiver education and support) should also be an
integral component of strategies seeking to improve patients’ CKD awareness, treatment
adherence, and achievement of CKD care goals.[33–35] While such interventions have proved
successful in other diseases, a recent randomized trial of patient navigators and enhanced per-
sonal health records in CKD failed to demonstrate a meaningful impact on multiple CKD out-
comes.[36] The study, however, may have been underpowered and high risk patients were not
specifically targeted. Additional work in this area is needed.
The PCPs in our study also identified several of their own challenges in caring for patients
with CKD, including limited CKD knowledge, less familiarity with CKD guidelines, and diffi-
culty in managing the complexity of multiple comorbid illnesses. A belief that CKD is incur-
able may also reinforce these barriers. Nephrology is frequently cited as a difficult topic area by
trainees pursuing subspecialty training in disciplines other than Nephrology.[37] Deficiencies
in CKD knowledge relative to other topics such as diabetes mellitus have been identified in
Internal Medicine residents in-training.[38, 39] In addition, among 651 surveyed residents,
28% were unaware of the existence of CKD guidelines at a time when the Kidney Disease Out-
comes Quality Initiative (K/DOQI) guidelines had been published for 5 years.[40] Since then,
the K/DOQI guidelines have largely been supplanted by multiple, lengthy consensus docu-
ments from the Kidney Disease Improving Global Outcomes (KDIGO) consortium. KDIGO
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guidelines are targeted to nephrologists, and not surprisingly, robust implementation by PCPs
has been limited in both the United States and elsewhere.[19, 41, 42] This is consistent with
findings from our study, where 45% of PCPs reported not following CKD guidelines. Further-
more, most of the PCPs in our study reported feeling comfortable managing their patients
with CKD, but less comfortable managing CKD-associated complications (e.g., metabolic aci-
dosis, bone disorders, or anemia). This suggests PCPs may be comfortable with the premise of
managing patients with CKD but are less well-prepared to actually implement guideline spe-
cific therapies.
Clear and concise CKD guidelines are needed to facilitate greater implementation by PCPs.
To help address CKD knowledge gaps and to increase recognition and utilization of CKD
guidelines, both the National Kidney Foundation (NKF) and the American College of Physi-
cians have published CKD algorithms targeted to PCPs.[43, 44] In addition, NKF has launched
CKDinform, a collection of evidence-based resources and protocols, to educate PCPs on best
practice in early-stage CKD management.[45] Greater dissemination and uptake of these
resources within primary care and enhanced early education of primary care trainees in the
key aspects of CKD management may improve PCPs provision of guideline-concordant CKD
care.[9] In addition, since PCPs often care for patients with multiple medication conditions,
these strategies should aim to reconcile any discordant treatment goals when managing CKD
in the context of multi-morbidity. Opposing treatment goals could increase the risk of death,
hospitalization, and emergency department visits in this population.[46]
Furthermore, systems-level barriers to PCPs providing CKD care included insufficient time
for managing complicated disease processes, limited reimbursement, rigid EMR templates,
and inadequate clinical and educational resources. Computerized decision support systems
have been increasingly implemented within electronic health records to facilitate delivery of
guideline concordant care, and may be particularly useful among PCPs who are often charged
with managing patients’ multiple and/or complex medical conditions during brief clinical
encounters. [47] The literature, however, demonstrates mixed results to date on the impact of
EMR and clinical support tools in CKD management. The introduction, for example, of auto-
mated eGFR reporting has been associated with increased identification of CKD, but only
marginal improvements in care as measured by percentage of late referrals to Nephrology or
prescription of renin angiotensin aldosterone system antagonists.[48–50] Similarly, clinical
decision support systems have resulted in only small improvements in physician adherence to
CKD guidelines.[51–54] Although desired by most PCPs, additional work is needed to under-
stand how best to implement electronic support tools to meaningfully impact patient care and
outcomes.
In addition to clear and concise guidelines and decision support, PCPs desired more robust
implementation of patient-centered medical homes, and/or greater ease in accessing multi-dis-
ciplinary care teams that include dietitians and pharmacists. Currently, PCPs report a lack of
resources and infrastructure to support effective CKD care. Value-based care models such as
accountable care organizations (ACOs) and Patient-Centered Medical Homes have the poten-
tial to transform care delivery and provide PCPs with additional resources to provide optimal
CKD care, particularly for patients with multiple comorbidities. Given the complexity of CKD,
increased partnerships between PCPs and other providers may also facilitate more efficient
and effective CKD care delivery. To this end, a recent randomized trial demonstrated small
improvements in medication management in patients with CKD when community pharma-
cists received focused training in CKD.[55] Broad implementation of such programs that facil-
itate delivery of optimal CKD care, however, remains challenging in light of time and financial
pressures. Results from technology-based intervention trials such as the Kidney Awareness
Registry and Education (KARE) study, a study evaluating the effectiveness of an electronic
Barriers to PCP management of CKD
PLOS ONE | https://doi.org/10.1371/journal.pone.0221325 August 22, 2019 14 / 19
CKD registry and self-management support program that consists of automated telephone
modules and health coaching, may ultimately inform potential solutions for the primary care
setting.[56] As such, interventions that combine patient education and self-management sup-
port with resources that facilitate provision of optimal CKD management within primary care
will be critical to addressing the multiple barriers voiced by PCPs. Ultimately, efforts to raise
awareness of CKD in the social conscious–as has been achieved with cardiovascular disease
and breast cancer, for example–may help physicians and patients find shared goals. Given the
challenges, it would be reasonable for PCPs to steer resources toward those patients at highest
risk for CKD progression or related events such as cardiovascular disease.[57–61] Population
risk stratification by eGFR and albuminuria are the best clinically available metrics, although
utilization remains low.[41, 62]
The limitations of this study deserve mention. The sample size is small and the perspectives
of the physicians in this study may not represent all of the practice challenges across the diver-
sity of primary care providers (including nurse practitioners and physician assistants) or prac-
tice settings. However, our study included participants representing diverse sociodemographic
and practice characteristics. Second, our study targeted primary care physicians. Focus groups
with patients may also provide additional insights regarding barriers to caring for patients
with CKD in primary care settings.
In conclusion, PCPs identified multiple modifiable patient-, provider-, and systems-level
barriers to the optimal care of patients with CKD. These physicians also identified potential
facilitators to providing better CKD care in the primary care setting. To improve the care and
clinical outcomes of patients with CKD and achieve Healthy People 2020 CKD objectives,
efforts are needed to improve dissemination of tools and resources that can be implemented
in primary care to facilitate improved patient awareness of CKD.[63] Improving patients’
access to self-management resources to further help mitigate their CKD risks is also needed.
Additionally, interventions and health care delivery innovations that enhance PCPs’ CKD
knowledge, facilitate PCPs’ provision of guideline concordant care, and/or integrate multidis-
ciplinary teams may improve PCPs’ capacity to effectively care for patients with CKD.
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